modifi
vaccinia
viru
ankara
mva
attenu
poxviru
frequent
use
viral
vector
mva
deriv
chorioallantoi
vaccinia
viru
strain
ankara
serial
passag
chicken
embryo
fibroblast
cef
time
result
major
delet
viral
genom
render
mva
replicationdefici
mammalian
mva
use
smallpox
vaccin
regimen
test
numer
clinic
trial
result
immun
studi
subject
without
seriou
advers
moreov
mvabas
vaccin
also
prove
safe
immunocompromis
nonhuman
given
impress
safeti
record
combin
capac
encod
gene
interest
kb
size
mva
hold
promis
vaccin
vector
vaccin
recombin
r
mva
lead
effici
induct
humor
cellular
immun
respons
target
protein
encod
insert
transgen
review
ref
favour
properti
consider
interest
develop
rmvabas
vaccin
variou
infecti
diseas
cancer
reflect
steadi
increas
number
clinic
trial
perform
rmva
recent
despit
frequent
test
clinic
trial
cellular
tropism
mva
particularli
relev
anim
model
studi
limit
extent
even
though
poxviru
lifecycl
complic
gener
poxvirus
enter
target
cell
via
direct
fusion
cell
membran
cellular
receptor
enabl
either
process
identifi
mva
promiscu
infect
almost
cell
type
put
cellular
receptor
expect
ubiquit
express
protein
share
differ
cell
extens
research
perform
vaccinia
viru
vacv
parent
pathogen
replicationcompet
poxviru
close
relat
mva
implic
import
role
cell
surfac
proteoglycan
vacv
ident
similar
protein
could
involv
attach
entri
mva
target
cell
recombin
virus
express
fluoresc
report
protein
sensit
trace
vitro
vivo
instrument
improv
understand
tropism
differ
previou
vitro
studi
human
peripher
blood
mononuclear
cell
pbmc
perform
determin
cellular
tropism
vacv
show
recombin
vacv
express
green
fluoresc
protein
gfp
preferenti
infect
profession
antigenpres
cell
apc
accord
result
similar
vitro
infect
studi
rmva
express
gfp
rmvagfp
also
demonstr
apc
preferenti
infect
directli
follow
apoptosi
target
furthermor
determin
tissu
tropism
mva
vivo
mice
previous
inocul
via
intranas
intraperiton
ip
subcutan
sc
rout
rmva
express
studi
shown
follow
instil
rmvainfect
cell
could
detect
nasalassoci
lymphoid
tissu
nalt
lung
drain
lymph
node
ln
lung
follow
ip
sc
inject
rmvaencod
luciferas
detect
lymphoid
organ
lung
liver
ovari
mous
studi
rmvagfp
demonstr
predomin
infect
dendrit
cell
dc
spleen
hour
post
administr
hpa
howev
studi
rmvagfp
administ
standard
immun
rout
studi
focus
tissu
tropism
mice
natur
phenotyp
cell
target
mva
vivo
relev
anim
model
administr
via
rout
commonli
use
vaccin
remain
larg
unknown
order
extens
elucid
tissu
cell
tropism
mva
perform
vitro
ex
vivo
vivo
infect
studi
rmvagfp
addit
compar
vivo
cell
tropism
mva
im
inject
tropism
direct
deliveri
respiratori
tract
demonstr
predomin
infect
mhc
class
ii
dc
rmvagfp
vitro
human
pbmc
ex
vivo
mous
lung
explant
vivo
rmvagfp
detect
interdigit
cell
myocyt
myocyt
im
inject
wherea
direct
administr
rmvagfp
respiratori
tract
led
preferenti
target
alveolar
macrophag
mice
dc
nonhuman
primat
respect
sinc
gfp
cell
subsequ
detect
ln
drain
site
administr
conclud
rmvagfpinfect
cell
migrat
secondari
lymphoid
tissu
direct
target
profession
apc
involv
shape
immun
respons
determin
cellular
tropism
mva
vitro
human
pbmc
inocul
rmvagfp
increment
multipl
infect
moi
rang
percentag
gfp
cell
within
differ
cell
popul
determin
flow
cytometri
h
postinocul
hladrhigh
dc
monocyt
readili
infect
rmvagfp
even
low
moi
hladr
blymphocyt
also
easili
infect
rmvagfp
follow
nk
cell
contrast
tlymphocyt
refractori
infect
rmvagfp
fig
determin
mva
tropism
respiratori
tract
mous
lung
slice
prepar
inocul
ex
vivo
rmvagfp
h
postinocul
emigr
cell
lung
slice
cultur
supernat
singl
cell
suspens
lung
tissu
analys
presenc
gfp
cell
use
flow
cytometri
interestingli
gfp
cell
mainli
present
supernat
inocul
lung
slice
cultur
howev
could
also
detect
singl
cell
suspens
fig
phenotyp
gfp
tissueresid
lung
cell
show
predomin
rmvagfp
infect
myeloid
cell
commonli
identifi
howev
myeloid
cell
doubl
posit
also
infect
fig
blymphocyt
infect
limit
extent
wherea
singl
posit
cell
tlymphocyt
found
refractori
infect
fig
order
determin
tissu
cell
tropism
mva
vivo
rmvagfp
administ
im
respiratori
tract
three
differ
anim
speci
mice
ferret
nonhuman
primat
fig
respiratori
tract
administr
perform
instil
intratrach
inocul
aerosol
aer
inhal
depend
anim
model
importantli
rout
respect
anim
model
allow
rmvagfp
deposit
lower
respiratori
tract
first
plaqu
form
unit
pfu
rmvagfp
administ
mice
via
im
rout
hpa
mice
sacrif
determin
optim
dose
timepoint
followup
experi
ferret
nonhuman
primat
im
inject
rmvagfp
mice
gfp
cell
consist
detect
hind
leg
muscl
rmvagfp
inject
direct
confoc
laser
scan
microscopi
clsm
muscl
slice
result
detect
gfp
fluoresc
muscl
fiber
fig
supplementari
figur
phenotyp
character
dual
stain
subsequ
clsm
immunohistochemistri
ihc
prove
difficult
mous
tissu
howev
myocyt
clearli
infect
fig
gfp
never
found
isotyp
control
stain
hind
leg
muscl
fig
furthermor
gfp
interdigit
cell
detect
muscl
identifi
either
macrophagedclik
morpholog
part
endomysium
connect
tissu
separ
muscl
fiber
fig
use
ihc
gfp
cell
never
found
front
leg
muscl
use
neg
control
fig
h
instil
rmvagfp
mice
gfp
cell
detect
nasal
turbin
lung
mice
inocul
rel
larg
volum
directli
expos
nasal
caviti
lung
nasal
turbin
gfp
cell
exclus
observ
epitheli
layer
morpholog
epitheli
cell
lung
gfp
cell
also
detect
epithelium
bronchiol
howev
singl
gfp
cell
amlik
morpholog
also
observ
lumen
alveoli
ihc
clsm
fig
e
data
show
rmvagfp
cell
consist
detect
anatom
site
administr
infect
cell
morpholog
resembl
epitheli
cell
lung
mice
inocul
via
rout
obtain
necropsi
singl
cell
suspens
prepar
determin
phenotyp
gfp
cell
multicolour
flow
cytometri
supplementari
figur
gfp
cell
lung
predominantli
defin
siglecf
howev
gfp
dc
defin
mhc
class
ii
also
detect
albeit
lesser
extent
fig
similar
result
observ
hpa
wherea
gfp
cell
could
detect
lung
hpa
data
shown
notabl
gfp
cell
select
hpa
subsequ
character
basi
express
variou
surfac
marker
revers
gate
found
constitut
largest
proport
gfp
cell
fig
determin
whether
rmvagfpinfect
cell
migrat
drain
ln
inguin
ln
ingln
drain
hind
leg
muscl
mediastin
ln
medln
drain
chest
examin
presenc
gfp
cell
im
inject
instil
respect
intern
neg
control
axillari
axln
drain
front
leg
muscl
im
inject
ingln
instil
use
determin
whether
rmvagfp
could
detect
system
blood
spleen
sampl
analys
presenc
gfp
cell
im
inject
gfp
cell
detect
singl
cell
suspens
drain
ingln
earli
hpa
mainli
mice
receiv
highest
dose
pfu
rmvagfp
gfp
cell
hardli
detect
later
timepoint
never
observ
control
axln
fig
left
panel
notabl
gfp
cell
also
detect
system
white
blood
cell
wbc
singl
cell
suspens
spleen
hpa
fig
instil
rmvagfp
low
number
gfp
cell
detect
medln
timepoint
control
ingln
fig
left
panel
similar
im
rmvagfp
inject
gfp
cell
detect
system
wbc
spleen
instil
fig
collect
data
illustr
im
inject
instil
gfp
cell
detect
ln
drain
site
inocul
system
determin
optim
dose
kinet
gfp
express
mice
ferret
receiv
high
dose
pfu
rmvagfp
via
either
im
inject
inocul
sacrif
hpa
gfp
cell
detect
hind
leg
muscl
slice
im
inject
lung
slice
bronchoalveolar
lavag
bal
cell
inocul
respect
fig
although
direct
clsm
could
use
determin
phenotyp
gfp
cell
demonstr
rmvagfp
infect
cell
present
site
administr
hpa
bal
cell
wbc
singl
cell
suspens
lymphoid
tissu
obtain
ferret
directli
analys
gfp
express
flow
cytometri
perform
positiveneg
score
base
flow
cytometri
data
fig
bal
cell
consist
posit
inocul
gfp
cell
dissemin
site
administr
could
detect
ingln
drain
hind
leg
muscl
tracheabronchi
tb
ln
drain
lung
im
inject
inocul
respect
fig
c
system
rmvagfp
cell
detect
spleen
wbc
multipl
anim
howev
detect
consist
low
frequenc
gfp
cell
found
bal
im
inject
potenti
due
circul
gfp
cell
anim
reflect
gfp
cell
pbmc
note
tissu
score
posit
flow
cytometri
fig
appear
neg
fig
due
low
frequenc
gfp
event
supplementari
figur
illustr
tissu
score
posit
use
flow
cytometri
phenotyp
gfp
cell
ferret
experiment
challeng
due
lack
requir
ferretspecif
antibodi
direct
discrimin
surfac
antigen
therefor
revers
gate
gfp
event
observ
flow
cytometri
discrimin
three
differ
popul
base
known
scatter
properti
differ
cell
type
lymphocytelik
monocytelik
dclike
cell
supplementari
figur
notabl
gfp
cell
equal
distribut
differ
popul
bal
wbc
splenocyt
clear
prefer
dclike
cell
drain
ln
hind
leg
muscl
lung
im
inject
inocul
respect
suggest
migrat
rmvagfpinfect
dc
site
administr
drain
ln
fig
aerosol
aerosol
plume
consist
droplet
size
distribut
gener
within
plume
smaller
droplet
tendenc
toward
deposit
lower
airway
wherea
larger
droplet
like
deposit
nasal
caviti
conduct
airway
order
fulli
character
aerosol
predict
respiratori
tract
rmvagfp
may
deposit
cascad
impact
perform
aerosol
fraction
discret
droplet
size
rang
fraction
titrat
order
determin
size
aerosol
droplet
viabl
rmvagfp
present
supplementari
figur
fine
particl
fraction
fpf
percentag
rmva
particl
contain
droplet
calcul
mass
median
aerodynam
diamet
mmad
predict
target
lower
airway
nonhuman
primat
howev
use
facemask
interfac
ensur
nasal
cavityupp
airway
expos
aerosol
well
collect
result
confirm
rmvagfp
deliv
upper
lower
respiratori
tract
nonhuman
primat
via
aerosol
inhal
complet
ferret
experi
cynomolgu
macaqu
inocul
pfu
rmvagfp
im
inject
aerosol
aer
slice
either
hind
leg
muscl
lung
obtain
nonhuman
primat
necropsi
hpa
analys
direct
clsm
reveal
presenc
gfp
cell
im
inject
aer
inhal
respect
fig
reconstruct
zstack
obtain
clsm
nonhuman
primat
lung
slice
reveal
gfp
cell
predominantli
detect
lumen
alveoli
lesser
extent
directli
connect
epithelium
line
alveoli
fig
right
panel
supplementari
figur
direct
imag
muscl
lung
slice
clsm
allow
identif
phenotyp
gfp
cell
guid
collect
gfp
tissu
could
use
subsequ
dual
immunofluoresc
stain
interstiti
macrophag
mhc
class
ii
antigen
present
cell
detect
infrequ
muscl
coloc
gfp
could
observ
nonhuman
primat
receiv
rmvagfp
im
inject
howev
gfp
mainli
coloc
desmin
specif
marker
myocyt
fig
dual
immunofluoresc
stain
gfp
lung
slice
nonhuman
primat
inocul
aer
inhal
reveal
coloc
mhc
class
ii
apc
fig
morpholog
cell
resembl
dc
coloc
gfp
specif
marker
tlymphocyt
shown
epitheli
cell
cytokeratin
blymphocyt
observ
aer
inhal
fig
isotyp
control
stain
lung
slice
neg
fig
subsequ
bal
sampl
nonhuman
primat
inocul
aer
analys
multicolour
flow
cytometri
dc
hladr
eosinophil
hladr
hladr
neutrophil
hladr
blymphocyt
hladr
tlymphocyt
nonleukocyt
analys
gfp
express
supplementari
figur
respiratori
sampl
collect
im
inject
use
neg
control
inde
gfp
cell
detect
fig
rel
percentag
gfp
cell
within
subset
highest
blymphocyt
dc
fig
addit
gfp
eosinophil
neutrophil
nonleukocyt
probabl
repres
epitheli
cell
detect
fig
revers
gate
gfp
cell
show
dc
constitut
gfp
cell
largest
gfp
cell
popul
interestingli
although
blymphocyt
show
highest
rmvagfp
infect
rate
number
blymphocyt
recov
nonhuman
primat
lung
low
explain
low
contribut
blymphocyt
total
gfp
cell
popul
fig
f
determin
whether
rmvagfp
cell
nonhuman
primat
migrat
drain
ln
spread
system
wbc
singl
cell
suspens
ln
spleen
analys
flow
cytometri
perform
positiveneg
score
base
flow
cytometri
data
differ
tissu
found
bal
aer
inocul
macaqu
consist
posit
show
gfp
cell
migrat
drain
ingln
im
inject
nonhuman
primat
fig
howev
tbln
consist
gfp
aer
inhal
nonhuman
primat
fig
gfp
cell
never
detect
spleen
gfp
wbc
observ
im
inject
anim
fig
thu
apart
migrat
mvainfect
cell
drain
ln
system
spread
gfp
cell
detect
limit
extent
fig
note
tissu
score
posit
flow
cytometri
fig
appear
neg
fig
due
low
frequenc
gfp
event
supplementari
figur
illustr
tissu
score
posit
use
flow
cytometri
studi
systemat
assess
tissu
cell
tropism
vaccin
vector
mva
vitro
ex
vivo
vivo
use
rmva
express
fluoresc
report
protein
even
though
differ
anim
speci
administr
rout
use
demonstr
consist
predomin
infect
mhc
class
ii
apc
addit
differ
speci
local
myocyt
local
epitheli
cell
infect
either
im
inject
respiratori
administr
respect
vaccin
cornerston
control
measur
reduc
morbid
mortal
caus
infecti
diseas
howev
vaccin
hypervari
emerg
pathogen
challeng
exampl
season
influenza
vaccin
need
updat
almost
annual
antigen
match
emerg
drift
variant
virus
maintain
vaccin
efficaci
furthermor
case
emerg
pandem
strain
influenza
viru
time
product
pandem
influenza
vaccin
proven
rapid
construct
recombin
viral
vaccin
vector
mva
allow
easi
insert
multipl
antigen
choic
rapid
product
larg
number
vaccin
dose
attract
altern
convent
vaccin
product
addit
mva
consid
vaccin
deliveri
system
mani
infecti
diseas
despit
increas
number
success
clinic
trial
perform
rmvabas
vaccin
recent
surprisingli
littl
known
mode
action
vivo
tissu
cell
tropism
mva
particularli
ferret
model
golden
standard
influenza
viru
pathogenesi
studi
anim
model
close
relat
human
nonhuman
primat
gap
knowledg
could
potenti
hamper
futur
registr
mvabas
vaccin
use
human
studi
describ
use
rmvagfp
allow
detect
singl
rmvagfp
infect
cell
high
sensit
elucid
tropism
viral
vector
mva
vitro
tropism
investig
inocul
human
pbmc
rmvagfp
ex
vivo
tropism
inocul
mous
lung
explant
vivo
tropism
inocul
three
differ
anim
speci
via
two
differ
administr
rout
gener
myeloid
cell
mainli
dc
macrophag
preferenti
infect
rmvagfp
independ
experiment
set
anim
speci
rout
administr
direct
target
apc
mice
ferret
nonhuman
primat
confirm
suitabl
mva
vaccin
vector
sinc
involv
shape
immun
respons
note
relat
vector
tropism
vaccin
immunogen
alway
straightforward
exampl
optim
dc
infect
adenoviru
vector
result
increas
immunogen
nonhuman
upon
vitro
inocul
human
pbmc
rmvagfp
dc
monocyt
blymphocyt
express
mhc
class
ii
predominantli
infect
nk
cell
also
target
rmvagfp
fig
tlymphocyt
refractori
mva
infect
accord
previous
publish
data
obtain
vacv
addit
tropism
rmvagfp
assess
ex
vivo
respiratori
tract
mous
lung
slice
due
limit
use
surfac
marker
discrimin
distinct
dc
monocyt
popul
possibl
howev
gfp
cell
mainli
identifi
cell
like
fig
although
vitro
ex
vivo
studi
elucid
cellular
tropism
mva
interest
may
accur
reflect
vivo
situat
cell
infect
mva
site
administr
previou
vivo
studi
mainli
focus
tissu
tropism
wherea
studi
focus
cellular
tropism
vivo
administr
rmvagfp
mice
ferret
nonhuman
primat
via
im
respiratori
rout
consist
result
detect
gfp
cell
site
administr
preclin
clinic
studi
mva
commonli
administ
im
inject
howev
local
cell
type
initi
infect
mva
thu
far
identifi
show
directli
im
inject
rmvagfp
infect
myocyt
interdigit
cell
potenti
macrophag
dc
part
endomysium
fig
unfortun
unabl
determin
exact
phenotyp
rmvagfpinfect
interdigit
cell
nonhuman
primat
due
low
frequenc
gfp
cell
muscl
tissu
due
sensit
detect
gfp
cell
singl
cell
suspens
lung
bal
cell
identif
rmvagfp
cell
respiratori
administr
rmvagfp
feasibl
instil
mice
rel
larg
volum
rmvagfp
deliv
vector
nasal
turbin
lung
consequ
mvainfect
epitheli
cell
detect
nasal
turbin
lung
howev
lung
also
frequent
infect
fig
concord
result
obtain
studi
show
instil
mice
rmvagfp
result
infect
mhc
class
detect
target
myeloid
cell
also
observ
inocul
ferret
rmvagfp
fig
howev
lack
ferretspecif
antibodi
requir
distinguish
cell
popul
hamper
possibl
determin
exact
phenotyp
rmvagfpinfect
cell
contrast
mice
predomin
target
cell
rmvagfp
lung
nonhuman
primat
character
mhc
class
mhc
class
ii
dc
shown
flow
cytometri
bal
cell
situ
clsm
dual
immunofluoresc
stain
lung
tissu
fig
addit
preferenti
target
dc
rmvagfp
also
detect
epitheli
cell
eosinophil
neutrophil
flow
cytometri
bal
cell
highest
infect
rate
observ
blymphocyt
number
blymphocyt
present
bal
obtain
nonhuman
primat
low
fig
dc
larg
contribut
total
number
rmvagfp
cell
neutrophil
also
form
substanti
compon
interestingli
shown
intraderm
inject
mva
mice
neutrophil
becom
infect
mva
subsequ
migrat
drain
ln
bone
marrow
prime
phenotyp
differ
tlymphocyt
addit
detect
site
administr
gfp
cell
also
detect
respect
drain
ln
either
im
inject
administr
airway
earli
hpa
except
instil
mice
led
detect
gfp
cell
drain
ln
later
timepoint
hpa
fig
possibl
medln
test
speci
instead
tbln
could
harvest
necropsi
mice
taken
togeth
data
suggest
administr
mva
local
infect
apc
subsequ
migrat
drain
ln
addit
gfp
cell
detect
system
blood
spleen
mice
particularli
hpa
fig
ferret
nonhuman
primat
euthan
hpa
could
explain
system
spread
mvagfp
cell
observ
limit
extent
fig
standard
rout
administr
mvabas
vaccin
intramuscular
im
inject
howev
induct
protect
mucos
immun
respiratori
pathogen
deliveri
mva
respiratori
tract
consid
review
ref
studi
rmvagfp
administ
respiratori
tract
nonhuman
primat
aerosol
best
possibl
proxi
futur
studi
mvabas
respiratori
vaccin
importantli
aerosol
droplet
size
nebul
deliveri
system
chosen
studi
allow
exposur
entir
upper
lower
respiratori
tract
infecti
viru
allow
accur
definit
target
cell
supplementari
figur
furthermor
aerosol
deliveri
extens
investig
altern
vaccin
deliveri
inject
abolish
necess
hypoderm
needl
facilit
safeti
largescal
vaccin
campaign
develop
countri
high
preval
bloodborn
infect
need
complic
infrastructur
dispos
potenti
contamin
needl
final
direct
administr
vaccin
respiratori
tract
could
lead
effici
induct
local
immun
respons
lead
increas
protect
respiratori
pathogen
evalu
extens
liveattenu
influenza
vaccin
administ
children
show
nasal
spray
administr
led
effici
induct
local
mucos
iga
antibodi
similar
advantag
potenti
exist
rmva
use
live
vaccin
respiratori
pathogen
could
lead
induct
local
humor
cellular
immun
respons
tissueresid
tlymphocyt
summari
first
comprehens
examin
tropism
mva
vitro
ex
vivo
vivo
differ
speci
preferenti
target
apc
rmvagfp
demonstr
vivo
anim
model
regardless
rout
administr
furthermor
deliveri
rmvagfp
respiratori
tract
nonhuman
primat
aerosol
also
result
infect
local
epitheli
cell
im
inject
result
infect
myocyt
mice
preferenti
infect
dc
opposit
case
nonhuman
primat
interest
preferenti
target
dc
would
advantag
vectorbas
vaccin
notori
ineffici
apc
comparison
proxi
sequenc
event
vaccin
human
mva
nonhuman
primat
data
show
directli
administr
mva
infect
local
apc
case
aerosol
deliveri
mhc
class
ii
dc
lung
rmvagfp
dc
subsequ
migrat
drain
ln
present
antigen
via
mhc
class
ii
respond
cell
lead
effici
shape
immun
respons
review
ref
previous
shown
infect
dc
mva
induc
matur
potenti
form
basi
direct
crosspresent
mvaencod
antigen
hla
class
whether
rmvagfpinfect
apc
present
antigen
respond
cell
directli
via
uptak
antigen
dc
mhc
class
ii
crosspresent
examin
studi
data
obtain
studi
show
direct
target
profession
apc
could
explain
excel
immunogen
mvabas
vaccin
knowledg
target
specif
cell
type
mva
could
guid
futur
vaccin
design
deliveri
strategi
use
human
pmbc
scientif
research
approv
medic
ethic
committe
metc
erasmu
mc
permit
number
particip
gave
inform
consent
permiss
use
materi
studi
infecti
diseas
identifi
inform
publish
work
describ
carri
accord
code
ethic
world
medic
associ
declar
helsinki
anim
experi
conduct
strict
complianc
european
guidelin
eu
direct
anim
test
anim
protocol
approv
independ
anim
experiment
ethic
review
committe
erasmu
mc
permit
number
anim
welfar
observ
daili
basi
minim
anim
suffer
anim
handl
perform
light
anaesthesia
use
isofluran
oxygen
mice
mixtur
mgkg
ketamin
mgkg
medetomidin
ferret
nonhuman
primat
antagon
effect
medetomidin
atipamezol
administ
handl
rmvagfp
gener
homolog
recombin
describ
briefli
mva
clonal
isol
serv
parent
viru
gener
rmvagfp
vector
plasmid
use
direct
insert
gfp
code
sequenc
transcript
control
natur
vacv
late
promotor
delet
iii
site
mva
genom
viru
stock
gener
cef
purifi
ultracentrifug
sucros
reconstitut
mm
nacl
mm
trishcl
buffer
ph
titr
rmvagfp
stock
determin
plaqu
assay
cef
construct
valid
pcr
nucleotid
sequenc
transgen
express
variou
cell
type
pbmc
isol
blood
obtain
healthi
human
seed
lowadher
vbottom
plate
cellswel
subsequ
cell
inocul
rmvagfp
increment
moi
rang
moi
titrat
h
wash
incub
h
roswel
park
memori
institut
rpmi
medium
lonza
supplement
heatinactiv
foetal
bovin
serum
hifb
greiner
bioon
penicillin
streptomycin
lonza
lglutamin
lonza
psg
h
cell
harvest
stain
bd
pharmingen
bd
pharmingen
bd
pharmingen
bd
pharmingen
becton
dickinson
hladrpb
biolegend
combin
livedead
aqua
fixabl
stain
invitrogen
cell
analys
flow
cytomet
fac
canto
ii
percentag
infect
cell
gfp
within
respect
subset
determin
use
fac
diva
softwar
bd
bioscienc
lung
mice
receiv
im
inject
rmvagfp
gfp
event
detect
lung
inflat
lowmelt
pb
mix
equal
part
dulbecco
modifi
eagl
medium
dmem
lonza
biowhittak
ham
medium
gibco
supplement
hifb
psg
amphotericin
b
institut
pharmaci
lung
slice
approxim
thick
cut
use
ex
vivo
infect
rmvagfp
describ
short
h
postinocul
singl
cell
suspens
obtain
digest
describ
subsequ
stain
bd
pharmingen
bd
pharmingen
bd
pharmingen
bd
pharmingen
combin
livedead
aqua
fixabl
stain
sampl
acquir
flow
cytomet
fac
canto
ii
analys
use
fac
diva
softwar
bd
bioscienc
one
mockinfect
lung
slice
exclud
fac
analysi
due
high
aspecif
background
specifi
pathogen
free
femal
mice
n
purchas
charl
river
hous
individu
ventil
cage
ivc
unit
access
food
water
ad
libitum
mice
inocul
pfu
rmvagfp
pb
administ
either
im
inject
hind
leg
instil
mice
euthan
cervic
disloc
isofluran
anaesthesia
hpa
euthanasia
blood
ingln
spleen
head
lung
trachea
obtain
anim
analysi
addit
axln
leg
muscl
collect
im
inject
anim
medln
collect
instil
mice
four
month
old
femal
ferret
mustela
putoriu
furo
hous
neg
pressur
hepafilt
isol
cage
provid
commerci
food
pellet
water
ad
libitum
ferret
inocul
pfu
rmvagfp
pb
via
either
im
inject
hind
leg
inocul
ml
ferret
euthan
exsanguin
hpa
deep
ketamin
sedat
mgkg
bodi
weight
fig
blood
ingln
spleen
nose
trachea
primari
bronchu
lung
bal
tbln
obtain
anim
leg
muscl
exclus
obtain
im
inject
ferret
character
aerosol
droplet
diamet
follow
nebul
rmvagfp
pfu
rmvagfp
dilut
ml
pb
nebul
use
vibrat
mesh
nebul
aeroneb
lab
nebul
aerogen
limit
previous
mmad
result
aerosol
determin
use
cascad
impactor
litr
per
minut
vacuum
flow
rate
ngi
copley
scientif
four
male
healthi
cynomolgu
macaqu
macaca
fasciculari
obtain
reus
one
year
nonleth
measl
vaccin
challeng
experi
anim
hous
neg
pressur
hepafilt
isol
cage
inocul
pfu
rmvagfp
pb
via
either
im
inject
hind
leg
aerosol
inhal
briefli
rmvagfp
administ
use
nebul
aeroneb
lab
nebul
aerogen
limit
connect
mm
tpiec
use
silicon
pediatr
resuscit
mask
comforts
silicon
mask
assembl
small
monaghan
medic
corp
interfac
nonhuman
use
method
pfu
rmvagfp
ml
nebul
administ
nonhuman
primat
anim
euthan
exsanguin
hpa
deep
ketamin
sedat
mgkg
bodi
weight
fig
blood
inguin
ln
spleen
nasal
septum
nasal
concha
trachea
primari
bronchu
lung
bal
tbln
collect
anim
leg
muscl
exclus
obtain
im
inject
nonhuman
primat
blood
sampl
mice
ferret
nonhuman
primat
collect
vacuett
tube
contain
anticoagul
pure
wbc
obtain
treatment
edta
blood
red
blood
cell
rbc
lysi
buffer
roch
diagnost
bal
perform
postmortem
ferret
nonhuman
primat
direct
infus
ml
pb
lung
follow
immedi
recoveri
fluid
lymphoid
organ
collect
anim
necropsi
iscov
modifi
dulbecco
medium
imdm
lonza
biowhittak
supplement
hifb
psg
singl
cell
suspens
gener
use
cell
strainer
falcon
spleen
singl
cell
suspens
subsequ
treat
rbc
lysi
buffer
order
remov
erythrocyt
collect
wbc
bal
cell
singl
cell
suspens
lymphoid
organ
directli
analys
presenc
gfp
flow
cytometri
fac
canto
ii
bd
bioscienc
gfp
sampl
subsequ
stain
order
phenotyp
gfp
event
see
mous
ingln
wbc
sampl
im
inject
n
spleen
instil
n
exclud
fac
analysi
due
high
background
signal
mous
lung
either
fix
inflat
formalin
complet
singl
cell
suspens
prepar
digest
formalinfix
tissu
subsequ
analys
immunohistochemistri
andor
dual
immunofluoresc
stain
singl
cell
suspens
prepar
treatment
uml
collagenas
type
invitrogen
mgml
dnase
roch
diagnost
dilut
hank
balanc
salt
solut
hbss
gibco
h
follow
filtrat
cell
strainer
excess
erythrocyt
remov
treatment
rbc
lysi
buffer
necessari
singl
cell
suspens
use
directli
detect
gfp
flow
cytometri
gfp
sampl
subsequ
stain
order
phenotyp
gfp
event
see
ferret
nonhuman
primat
lung
inflat
lowmelt
pb
mix
equal
part
dmemham
medium
gibco
supplement
hifb
psg
amphotericin
b
lung
slice
approxim
thick
cut
use
direct
analysi
gfp
fluoresc
use
clsm
direct
detect
gfp
lung
slice
fix
formalin
paraffin
embed
subsequ
analys
immunohistochemistri
andor
dual
immunofluoresc
stain
freshli
isol
wbc
bal
cell
singl
cell
suspens
prepar
lymphoid
organ
lung
analys
directli
gfp
express
use
fac
canto
ii
flow
cytomet
fac
diva
softwar
bd
bioscienc
approxim
event
obtain
per
sampl
allow
detect
low
frequent
gfp
popul
sampl
posit
gfp
subsequ
stain
phenotyp
gfp
cell
cell
obtain
mous
lung
subdivid
dc
eosinophil
neutrophil
tlymphocyt
blymphocyt
nk
cell
block
fc
receptor
stain
siglecfp
bd
bd
ebiosci
ebiosci
ebiosci
bd
bd
bd
ebiosci
follow
bd
bd
ebiosci
ebiosci
bal
cell
obtain
nonhuman
primat
subdivid
dc
eosinophil
neutrophil
monocyt
epitheli
cell
tlymphocyt
blymphocyt
block
fc
receptor
human
serum
stain
ebiosci
beckman
coulter
bd
bd
ebiosci
biolegend
follow
bd
bd
bd
biolegend
bd
bd
mice
nonhuman
primat
dead
cell
disregard
analysi
exclud
cell
stain
livedead
aqua
fixabl
stain
percentag
gfp
cell
within
cell
popul
determin
use
fac
lsr
ii
bd
bioscienc
determin
tropism
rmvagfp
upper
respiratori
tract
complet
mous
head
fix
formalin
head
subsequ
decalcifi
eight
day
use
edta
buffer
split
two
halv
decalcif
continu
anoth
two
day
follow
embed
paraffin
determin
cellular
tropism
upper
respiratori
tract
ferret
nonhuman
primat
nasal
tissu
ferret
harvest
formalin
fix
nasal
septa
concha
nonhuman
primat
harvest
fix
tissu
decalcifi
embed
paraffin
requir
furthermor
addit
analysi
nasal
caviti
lung
trachea
primari
bronchi
anim
collect
formalin
determin
tropism
rmvagfp
muscl
hind
front
leg
muscl
harvest
pb
possibl
exact
site
rmvagfp
inject
harvest
subsequ
slice
cut
direct
examin
gfp
fluoresc
use
clsm
posit
slice
formalinfix
paraffinembed
follow
immunohistochemistri
andor
dual
immunofluoresc
stain
anim
model
front
leg
muscl
form
appropri
neg
control
inocul
hind
leg
muscl
tissu
slice
obtain
muscl
tissu
agaroseinfl
lung
directli
analys
gfp
fluoresc
use
clsm
system
fit
axio
observ
invert
microscop
zeiss
imag
video
gener
use
zen
softwar
gfp
muscl
mice
lung
slice
cynomolgu
macaqu
transfer
wv
paraformaldehyd
pb
permeabil
vv
min
subsequ
counterstain
nuclei
invitrogen
section
formalinfix
paraffinembed
tissu
cut
deparaffinis
order
detect
gfp
antigen
retriev
perform
mm
citrat
buffer
histolog
evalu
sampl
subsequ
incub
overnight
antigfp
polyclon
rabbit
antibodi
invitrogen
follow
incub
secondari
goatantirabbitbiotin
antibodi
dako
streptavidinhrp
dako
gfp
detect
use
aec
substrat
slide
counterstain
mous
nonhuman
primat
hind
leg
muscl
lung
tissu
dual
immunofluoresc
stain
perform
antigen
retriev
citrat
buffer
tissu
incub
normal
goat
serum
bioconnect
pb
mous
tissu
stain
rabbit
antigfp
invitrogen
rabbit
igg
isotyp
r
system
follow
goatantirabbit
alexa
fluor
af
life
technolog
nonhuman
primat
tissu
stain
rabbit
antigfp
combin
mousederiv
antibodi
antidesmin
abcam
anticytokeratin
dako
abd
serotec
antimhc
class
ii
hladpdqdr
dako
novocastra
biosystem
newcastl
ltd
dako
neg
control
lung
slice
stain
rabbit
igg
isotyp
combin
either
mous
isotyp
r
system
subsequ
tissu
stain
goatantirabbit
alexa
fluor
af
goatantimous
invitrogen
sampl
treat
prolong
gold
antifad
reagent
dapi
life
technolog
analysi
use
clsm
system
fit
axio
observ
invert
microscop
zeiss
imag
analys
use
zen
softwar
data
gener
analys
studi
includ
publish
articl
supplementari
inform
file
